Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
According to the analysis, both medications lowered the chances of heart attack, stroke, and death from any cause
Categories: Metabolic, Performance
This information should be interpreted with a qualified healthcare provider and combined with your clinical biomarkers to support a more personalized conversation about GLP-1 candidacy
This drop closely correlates with the well-known reduction in regenerative capacity seen across multiple organ systems as we age
Yoshida R, Ninomiya Y
Standard AOD-9604 Dosing Protocol Subcutaneous Injection Dosing: Beginner: 250 mcg per dose, once daily Intermediate: 300-400 mcg per dose, once daily or divided into two doses Advanced: 500 mcg per dose, once daily or 250 mcg twice daily Oral Administration Dosing (if using oral formulation): Standard: 1-2 mg per dose, once daily on empty stomach Higher protocols: Up to 5-10 mg daily, as studied in clinical trials Frequency: Once daily (morning preferred) or twice daily (morning and early afternoon) Timing: Best administered on an empty stomach, typically upon waking or before exercise Cycle Length: 12-16 weeks for initial assessment, with potential for longer protocols based on response Off Cycle: 4-8 weeks between cycles, though not strictly required based on current research Note: Start at the lower end of the dosing range to assess individual tolerance
